PubMed:22547651
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-130 | Sentence | denotes | Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. |
| T2 | 131-262 | Sentence | denotes | Human skin immune homeostasis, and its regulation by specialized subsets of tissue-residing immune sentinels, is poorly understood. |
| T3 | 263-483 | Sentence | denotes | In this study, we identify an immunoregulatory tissue-resident dendritic cell (DC) in the dermis of human skin that is characterized by surface expression of CD141, CD14, and constitutive IL-10 secretion (CD141(+) DDCs). |
| T4 | 484-692 | Sentence | denotes | CD141(+) DDCs possess lymph node migratory capacity, induce T cell hyporesponsiveness, cross-present self-antigens to autoreactive T cells, and induce potent regulatory T cells that inhibit skin inflammation. |
| T5 | 693-822 | Sentence | denotes | Vitamin D(3) (VitD3) promotes certain phenotypic and functional properties of tissue-resident CD141(+) DDCs from human blood DCs. |
| T6 | 823-993 | Sentence | denotes | These CD141(+) DDC-like cells can be generated in vitro and, once transferred in vivo, have the capacity to inhibit xeno-graft versus host disease and tumor alloimmunity. |
| T7 | 994-1160 | Sentence | denotes | These findings suggest that CD141(+) DDCs play an essential role in the maintenance of skin homeostasis and in the regulation of both systemic and tumor alloimmunity. |
| T8 | 1161-1282 | Sentence | denotes | Finally, VitD3-induced CD141(+) DDC-like cells have potential clinical use for their capacity to induce immune tolerance. |
| T1 | 0-130 | Sentence | denotes | Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. |
| T2 | 131-262 | Sentence | denotes | Human skin immune homeostasis, and its regulation by specialized subsets of tissue-residing immune sentinels, is poorly understood. |
| T3 | 263-483 | Sentence | denotes | In this study, we identify an immunoregulatory tissue-resident dendritic cell (DC) in the dermis of human skin that is characterized by surface expression of CD141, CD14, and constitutive IL-10 secretion (CD141(+) DDCs). |
| T4 | 484-692 | Sentence | denotes | CD141(+) DDCs possess lymph node migratory capacity, induce T cell hyporesponsiveness, cross-present self-antigens to autoreactive T cells, and induce potent regulatory T cells that inhibit skin inflammation. |
| T5 | 693-822 | Sentence | denotes | Vitamin D(3) (VitD3) promotes certain phenotypic and functional properties of tissue-resident CD141(+) DDCs from human blood DCs. |
| T6 | 823-993 | Sentence | denotes | These CD141(+) DDC-like cells can be generated in vitro and, once transferred in vivo, have the capacity to inhibit xeno-graft versus host disease and tumor alloimmunity. |
| T7 | 994-1160 | Sentence | denotes | These findings suggest that CD141(+) DDCs play an essential role in the maintenance of skin homeostasis and in the regulation of both systemic and tumor alloimmunity. |
| T8 | 1161-1282 | Sentence | denotes | Finally, VitD3-induced CD141(+) DDC-like cells have potential clinical use for their capacity to induce immune tolerance. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 484-489 | gene:7056 | denotes | CD141 |
| T1 | 674-691 | disease:C0011603 | denotes | skin inflammation |
| R1 | T0 | T1 | associated_with | CD141,skin inflammation |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 674-691 | HP_0011123 | denotes | skin inflammation |
| T2 | 974-979 | HP_0002664 | denotes | tumor |
| T3 | 1141-1146 | HP_0002664 | denotes | tumor |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_22547651_2_0 | 326-340 | expanded | denotes | dendritic cell |
| SS2_22547651_2_0 | 342-344 | abbr | denotes | DC |
| SS1_22547651_4_0 | 693-705 | expanded | denotes | Vitamin D(3) |
| SS2_22547651_4_0 | 707-712 | abbr | denotes | VitD3 |
| AE1_22547651_2_0 | SS1_22547651_2_0 | SS2_22547651_2_0 | abbreviatedTo | dendritic cell,DC |
| AE1_22547651_4_0 | SS1_22547651_4_0 | SS2_22547651_4_0 | abbreviatedTo | Vitamin D(3),VitD3 |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 22547651-0#9#14#gene7056 | 9-14 | gene7056 | denotes | CD141 |
| 22547651-0#16#21#gene7056 | 16-21 | gene7056 | denotes | BDCA3 |
| 22547651-0#62#67#gene3586 | 62-67 | gene3586 | denotes | IL-10 |
| 22547651-0#112#129#diseaseC0011603 | 112-129 | diseaseC0011603 | denotes | skin inflammation |
| 22547651-0#112#129#diseaseC3875321 | 112-129 | diseaseC3875321 | denotes | skin inflammation |
| 22547651-0#112#129#diseaseC0011603 | 112-129 | diseaseC0011603 | denotes | skin inflammation |
| 22547651-0#112#129#diseaseC3875321 | 112-129 | diseaseC3875321 | denotes | skin inflammation |
| 22547651-0#112#129#diseaseC0011603 | 112-129 | diseaseC0011603 | denotes | skin inflammation |
| 22547651-0#112#129#diseaseC3875321 | 112-129 | diseaseC3875321 | denotes | skin inflammation |
| 22547651-3#9#12#gene1644 | 493-496 | gene1644 | denotes | DDC |
| 22547651-3#190#207#diseaseC0011603 | 674-691 | diseaseC0011603 | denotes | skin inflammation |
| 22547651-3#190#207#diseaseC3875321 | 674-691 | diseaseC3875321 | denotes | skin inflammation |
| 22547651-5#6#11#gene7056 | 829-834 | gene7056 | denotes | CD141 |
| 22547651-5#15#18#gene1644 | 838-841 | gene1644 | denotes | DDC |
| 22547651-5#121#146#diseaseC0018133 | 944-969 | diseaseC0018133 | denotes | graft versus host disease |
| 9#14#gene7056112#129#diseaseC0011603 | 22547651-0#9#14#gene7056 | 22547651-0#112#129#diseaseC0011603 | associated_with | CD141,skin inflammation |
| 9#14#gene7056112#129#diseaseC3875321 | 22547651-0#9#14#gene7056 | 22547651-0#112#129#diseaseC3875321 | associated_with | CD141,skin inflammation |
| 9#14#gene7056112#129#diseaseC0011603 | 22547651-0#9#14#gene7056 | 22547651-0#112#129#diseaseC0011603 | associated_with | CD141,skin inflammation |
| 9#14#gene7056112#129#diseaseC3875321 | 22547651-0#9#14#gene7056 | 22547651-0#112#129#diseaseC3875321 | associated_with | CD141,skin inflammation |
| 9#14#gene7056112#129#diseaseC0011603 | 22547651-0#9#14#gene7056 | 22547651-0#112#129#diseaseC0011603 | associated_with | CD141,skin inflammation |
| 9#14#gene7056112#129#diseaseC3875321 | 22547651-0#9#14#gene7056 | 22547651-0#112#129#diseaseC3875321 | associated_with | CD141,skin inflammation |
| 16#21#gene7056112#129#diseaseC0011603 | 22547651-0#16#21#gene7056 | 22547651-0#112#129#diseaseC0011603 | associated_with | BDCA3,skin inflammation |
| 16#21#gene7056112#129#diseaseC3875321 | 22547651-0#16#21#gene7056 | 22547651-0#112#129#diseaseC3875321 | associated_with | BDCA3,skin inflammation |
| 16#21#gene7056112#129#diseaseC0011603 | 22547651-0#16#21#gene7056 | 22547651-0#112#129#diseaseC0011603 | associated_with | BDCA3,skin inflammation |
| 16#21#gene7056112#129#diseaseC3875321 | 22547651-0#16#21#gene7056 | 22547651-0#112#129#diseaseC3875321 | associated_with | BDCA3,skin inflammation |
| 16#21#gene7056112#129#diseaseC0011603 | 22547651-0#16#21#gene7056 | 22547651-0#112#129#diseaseC0011603 | associated_with | BDCA3,skin inflammation |
| 16#21#gene7056112#129#diseaseC3875321 | 22547651-0#16#21#gene7056 | 22547651-0#112#129#diseaseC3875321 | associated_with | BDCA3,skin inflammation |
| 62#67#gene3586112#129#diseaseC0011603 | 22547651-0#62#67#gene3586 | 22547651-0#112#129#diseaseC0011603 | associated_with | IL-10,skin inflammation |
| 62#67#gene3586112#129#diseaseC3875321 | 22547651-0#62#67#gene3586 | 22547651-0#112#129#diseaseC3875321 | associated_with | IL-10,skin inflammation |
| 62#67#gene3586112#129#diseaseC0011603 | 22547651-0#62#67#gene3586 | 22547651-0#112#129#diseaseC0011603 | associated_with | IL-10,skin inflammation |
| 62#67#gene3586112#129#diseaseC3875321 | 22547651-0#62#67#gene3586 | 22547651-0#112#129#diseaseC3875321 | associated_with | IL-10,skin inflammation |
| 62#67#gene3586112#129#diseaseC0011603 | 22547651-0#62#67#gene3586 | 22547651-0#112#129#diseaseC0011603 | associated_with | IL-10,skin inflammation |
| 62#67#gene3586112#129#diseaseC3875321 | 22547651-0#62#67#gene3586 | 22547651-0#112#129#diseaseC3875321 | associated_with | IL-10,skin inflammation |
| 9#12#gene1644190#207#diseaseC0011603 | 22547651-3#9#12#gene1644 | 22547651-3#190#207#diseaseC0011603 | associated_with | DDC,skin inflammation |
| 9#12#gene1644190#207#diseaseC3875321 | 22547651-3#9#12#gene1644 | 22547651-3#190#207#diseaseC3875321 | associated_with | DDC,skin inflammation |
| 6#11#gene7056121#146#diseaseC0018133 | 22547651-5#6#11#gene7056 | 22547651-5#121#146#diseaseC0018133 | associated_with | CD141,graft versus host disease |
| 15#18#gene1644121#146#diseaseC0018133 | 22547651-5#15#18#gene1644 | 22547651-5#121#146#diseaseC0018133 | associated_with | DDC,graft versus host disease |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1877 | 9-14 | gene:7056 | denotes | CD141 |
| T1878 | 112-129 | disease:C0011603 | denotes | skin inflammation |
| T1879 | 16-21 | gene:7056 | denotes | BDCA3 |
| T1880 | 62-67 | gene:3586 | denotes | IL-10 |
| T1881 | 493-496 | gene:1644 | denotes | DDC |
| T1882 | 674-691 | disease:C0011603 | denotes | skin inflammation |
| R1 | T1877 | T1878 | associated_with | CD141,skin inflammation |
| R2 | T1877 | T1878 | associated_with | CD141,skin inflammation |
| R3 | T1879 | T1878 | associated_with | BDCA3,skin inflammation |
| R4 | T1879 | T1878 | associated_with | BDCA3,skin inflammation |
| R5 | T1880 | T1878 | associated_with | IL-10,skin inflammation |
| R6 | T1880 | T1878 | associated_with | IL-10,skin inflammation |
| R7 | T1881 | T1882 | associated_with | DDC,skin inflammation |
| R8 | T1881 | T1882 | associated_with | DDC,skin inflammation |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-130 | Sentence | denotes | Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. |
| TextSentencer_T2 | 131-262 | Sentence | denotes | Human skin immune homeostasis, and its regulation by specialized subsets of tissue-residing immune sentinels, is poorly understood. |
| TextSentencer_T3 | 263-483 | Sentence | denotes | In this study, we identify an immunoregulatory tissue-resident dendritic cell (DC) in the dermis of human skin that is characterized by surface expression of CD141, CD14, and constitutive IL-10 secretion (CD141(+) DDCs). |
| TextSentencer_T4 | 484-692 | Sentence | denotes | CD141(+) DDCs possess lymph node migratory capacity, induce T cell hyporesponsiveness, cross-present self-antigens to autoreactive T cells, and induce potent regulatory T cells that inhibit skin inflammation. |
| TextSentencer_T5 | 693-822 | Sentence | denotes | Vitamin D(3) (VitD3) promotes certain phenotypic and functional properties of tissue-resident CD141(+) DDCs from human blood DCs. |
| TextSentencer_T6 | 823-993 | Sentence | denotes | These CD141(+) DDC-like cells can be generated in vitro and, once transferred in vivo, have the capacity to inhibit xeno-graft versus host disease and tumor alloimmunity. |
| TextSentencer_T7 | 994-1160 | Sentence | denotes | These findings suggest that CD141(+) DDCs play an essential role in the maintenance of skin homeostasis and in the regulation of both systemic and tumor alloimmunity. |
| TextSentencer_T8 | 1161-1282 | Sentence | denotes | Finally, VitD3-induced CD141(+) DDC-like cells have potential clinical use for their capacity to induce immune tolerance. |
| T1 | 0-130 | Sentence | denotes | Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. |
| T2 | 131-262 | Sentence | denotes | Human skin immune homeostasis, and its regulation by specialized subsets of tissue-residing immune sentinels, is poorly understood. |
| T3 | 263-483 | Sentence | denotes | In this study, we identify an immunoregulatory tissue-resident dendritic cell (DC) in the dermis of human skin that is characterized by surface expression of CD141, CD14, and constitutive IL-10 secretion (CD141(+) DDCs). |
| T4 | 484-692 | Sentence | denotes | CD141(+) DDCs possess lymph node migratory capacity, induce T cell hyporesponsiveness, cross-present self-antigens to autoreactive T cells, and induce potent regulatory T cells that inhibit skin inflammation. |
| T5 | 693-822 | Sentence | denotes | Vitamin D(3) (VitD3) promotes certain phenotypic and functional properties of tissue-resident CD141(+) DDCs from human blood DCs. |
| T6 | 823-993 | Sentence | denotes | These CD141(+) DDC-like cells can be generated in vitro and, once transferred in vivo, have the capacity to inhibit xeno-graft versus host disease and tumor alloimmunity. |
| T7 | 994-1160 | Sentence | denotes | These findings suggest that CD141(+) DDCs play an essential role in the maintenance of skin homeostasis and in the regulation of both systemic and tumor alloimmunity. |
| T8 | 1161-1282 | Sentence | denotes | Finally, VitD3-induced CD141(+) DDC-like cells have potential clinical use for their capacity to induce immune tolerance. |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 207-213 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
| PD-UBERON-AE-B_T2 | 310-316 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
| PD-UBERON-AE-B_T3 | 771-777 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
| PD-UBERON-AE-B_T4 | 353-359 | http://purl.obolibrary.org/obo/UBERON_0002067 | denotes | dermis |
| PD-UBERON-AE-B_T5 | 506-511 | http://purl.obolibrary.org/obo/UBERON_0002391 | denotes | lymph |
| PD-UBERON-AE-B_T6 | 506-516 | http://purl.obolibrary.org/obo/UBERON_0000029 | denotes | lymph node |
| PD-UBERON-AE-B_T7 | 812-817 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 812-817 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
| PD-UBERON-AE-B_T2 | 207-213 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
| PD-UBERON-AE-B_T3 | 310-316 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
| PD-UBERON-AE-B_T4 | 771-777 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
| PD-UBERON-AE-B_T5 | 353-359 | http://purl.obolibrary.org/obo/UBERON_0002067 | denotes | dermis |
| PD-UBERON-AE-B_T6 | 506-511 | http://purl.obolibrary.org/obo/UBERON_0002391 | denotes | lymph |
| PD-UBERON-AE-B_T7 | 506-516 | http://purl.obolibrary.org/obo/UBERON_0000029 | denotes | lymph node |